Loading...

ABT ABBOTT LABORATORIES Management Changes 8-K Filing

BBTT

BT

ABBOTT LABORATORIES

(ABT)

2026 8-K

Board Changes Announced

Shareholder Lawsuit Update

Q1 Earnings Report

Abbott Acquires Exact

Bond Issuance Plan

Earnings Results

Trading Suspension Notice

Merger Announcement

Q3 Earnings Report

Financial Statements

Q1 Earnings Report

Earnings Results

Q3 Earnings Report

Earnings Reports

Annual Meeting of Shareholders

Earnings Reports

Credit Agreement

Earnings Reports

Earnings Reports

Earnings Releases

Management Appointments

Annual Meeting of Shareholders

Earnings Reports

By-Law Amendment

Results of Operations

External Links:

On April 24, 2026, Abbott Laboratories appointed Kevin Conroy to its Board and adopted a new 2026 Incentive Stock Program allowing the issuance of up to 140 million shares, replacing the previous 2017 program.

AI Assistant

ABBOTT LABORATORIES

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.